Wealthspire Advisors (New York)’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
2025
Q3
$4.24K Buy
2023
Q3
Sell
2023
Q2
$1.06M Sell
2023
Q1
$1.33M Sell
2022
Q4
$1.39M Sell
2022
Q3
$1.78M Buy
2022
Q2
$1.13M Sell
2022
Q1
$3.01M Buy
2021
Q4
$2.28M Buy
2021
Q3
$1.39M Buy
2019
Q1
Sell
2018
Q4
$0 Buy